MedPath
HSA Product

TEKCIS RADIONUCLIDE GENERATOR 2-50 GBQ

Product approved by Health Sciences Authority (SG)

Basic Information

TEKCIS RADIONUCLIDE GENERATOR 2-50 GBQ

GENERATOR

Regulatory Information

SIN15741P

July 10, 2019

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

June 4, 2025

XV09

Company Information

QT INSTRUMENTS (S) PTE LTD

QT INSTRUMENTS (S) PTE LTD

Active Ingredients

Sodium Molybdate (99Mo)

Strength: 2-50 GBq

Sodium Pertechnetate (99mTc)

Strength: 2/4/6/8/10/12/16/20/25/50 GBq

Detailed Information

Contraindications

**4.3. Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.

Indication Information

**4.1. Therapeutic indications** This medicinal product is for diagnostic use only. The eluate from the radionuclide generator (Sodium Pertechnetate (99mTc) Injection Ph. Eur.) is indicated for: - Labelling of various kits for radiopharmaceutical preparation developed and approved for radiolabelling with such solution. - Thyroid scintigraphy: direct imaging and measurement of thyroid uptake to give information on the size, position, nodularity and function of the gland in thyroid disease. - Salivary gland scintigraphy: diagnosis of chronic sialadenitis (e.g. Sjögren Syndrom) as well as to assess salivary gland function and duct patency in salivary glands disorders and monitoring of the response to therapeutic interventions (in particular radio iodine therapy). - Location of ectopic gastric mucosa (Meckel’s diverticulum). - Lacrimal duct scintigraphy to assess functional disorders of lacrimation and monitoring of the response to therapeutic interventions.

© Copyright 2025. All Rights Reserved by MedPath